Hedge Fund - Cr Intrinsic Investors
Sac Subsidiary Bio, Returns, Net Worth
CR Intrinsic Investors is one of SAC Capital's subsidiaries, and one of its foci is on the biopharmaceutical industry. CR Intrinsic has previously employed Mathew Martoma, a portfolio manager who was charged with insider trading by the SEC earlier this year. CR Intrinsic's $600 million settlement was the largest of its kind on record. The fund has an estimated $2 billion to $3 billion in assets under management.
|Fund Name:||Cr Intrinsic Investors|
|Change This QTR||0.00%|
Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).